Trulieve CAO discloses initial share and option holdings

Trulieve Cannabis Corp. filed an initial insider report for Chief Accounting Officer Brett R. Walsh, detailing his existing equity position.

Rhea-AI Filing Summary

Trulieve Cannabis Corp. filed an initial insider report for Chief Accounting Officer Brett R. Walsh, detailing his existing equity position. He directly holds 111,594 subordinate voting shares and a stock option to buy 7,160 subordinate voting shares at an exercise price of $21.48 per share, expiring on February 24, 2029. Footnotes explain multiple restricted stock unit grants from 2021 through 2025, each vesting over two years in 50% annual installments.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Walsh Brett R.

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
holding	Stock Option (Right to Buy)	--	--	--
holding	Subordinate Voting Shares	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 7,160 contracts (Direct); Subordinate Voting Shares — 111,594 shares (Direct)

Footnotes (2)

1. F1. The amount of securities beneficially owned in column 2 includes several grants of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. The reporting person: (i) was granted 6,696 RSUs on September 29, 2021, subject to 2-year vesting; the RSUS vested 50% each on December 1, 2022 and December 1, 2023; (ii) was granted 7,542 RSUs on February 24, 2022, subject to 2-year vesting; the RSUs vested 50% on each of December 29, 2023 and December 29, 2024; (iii) was granted 34,785 RSUs on July 25, 2023, subject to 2-year vesting; the RSUs vested 50% on each of December 1, 2024 and December 1, 2025; (iv) was granted 22,680 RSUs on March 8, 2024, subject to 2-year vesting; the RSUs vested 50% on December 1, 2025 and will vest 50% on December 1, 2026; and (v) was granted 58,529 RSUs on March 25, 2025, subject to 2-year vesting; the RSUs will vest 50% on December 1, 2026 and 50% on December 1, 2027.
2. F2. The options were granted on February 24, 2022, and vest 33% per year in equal installments, starting on December 1 of the grant year. One third of the options vested and became exercisable on each of December 1, 2022, December 1, 2023 and December 1, 2024.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Brett R. Walsh’s Form 3 for Trulieve Cannabis Corp. (TCNNF) report?

The Form 3 reports Brett R. Walsh’s existing equity holdings as Chief Accounting Officer. It shows 111,594 subordinate voting shares and a stock option for 7,160 shares, plus several restricted stock unit grants with two-year vesting schedules from 2021 through 2025.

How many Trulieve subordinate voting shares does Brett R. Walsh beneficially own on this Form 3?

The filing shows direct beneficial ownership of 111,594 subordinate voting shares. This figure includes shares underlying several restricted stock unit awards, each representing a contingent right to receive one subordinate voting share, subject to their respective vesting schedules described in the footnotes.

What stock options are reported for Brett R. Walsh in the Trulieve Form 3?

The Form 3 lists a stock option to buy 7,160 subordinate voting shares at an exercise price of $21.48 per share. The option was granted on February 24, 2022 and vests in three equal annual installments, becoming fully exercisable by December 1, 2024.

How are Brett R. Walsh’s restricted stock units structured at Trulieve Cannabis Corp. (TCNNF)?

The filing details five RSU grants from 2021–2025, including 6,696, 7,542, 34,785, 22,680 and 58,529 units. Each grant vests over two years, with 50% vesting on specified December dates in 2022, 2023, 2024, 2025, 2026 and 2027 respectively.

Does this Trulieve Form 3 show any insider buying or selling by Brett R. Walsh?

No transactions are reported. The entries are categorized as holdings, with transaction codes and directions marked unknown. The document serves to disclose Walsh’s existing share, option, and RSU positions rather than recording new purchases or sales.

What is the role of Brett R. Walsh at Trulieve Cannabis Corp. per this Form 3?

The Form 3 identifies Brett R. Walsh as an officer of Trulieve Cannabis Corp., serving as Chief Accounting Officer. It does not indicate that he is a director or a ten-percent owner, focusing instead on his officer status and related equity holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/10/2026 - 04:10 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Walsh Brett R.

(Last) (First) (Middle)

C/O TRULIEVE CANNABIS CORP.

3494 MARTIN HURST ROAD

(Street)

TALLAHASSEE FL 32312

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/28/2026

3. Issuer Name and Ticker or Trading Symbol
Trulieve Cannabis Corp. [ TRUL ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Subordinate Voting Shares	111,594(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(2)	02/24/2029	Subordinate Voting Shares	7,160	$21.48	D

Explanation of Responses:

1. The amount of securities beneficially owned in column 2 includes several grants of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. The reporting person: (i) was granted 6,696 RSUs on September 29, 2021, subject to 2-year vesting; the RSUS vested 50% each on December 1, 2022 and December 1, 2023; (ii) was granted 7,542 RSUs on February 24, 2022, subject to 2-year vesting; the RSUs vested 50% on each of December 29, 2023 and December 29, 2024; (iii) was granted 34,785 RSUs on July 25, 2023, subject to 2-year vesting; the RSUs vested 50% on each of December 1, 2024 and December 1, 2025; (iv) was granted 22,680 RSUs on March 8, 2024, subject to 2-year vesting; the RSUs vested 50% on December 1, 2025 and will vest 50% on December 1, 2026; and (v) was granted 58,529 RSUs on March 25, 2025, subject to 2-year vesting; the RSUs will vest 50% on December 1, 2026 and 50% on December 1, 2027.

2. The options were granted on February 24, 2022, and vest 33% per year in equal installments, starting on December 1 of the grant year. One third of the options vested and became exercisable on each of December 1, 2022, December 1, 2023 and December 1, 2024.

Remarks:

Exhibit 24 Power of Attorney filed herewith.

	/s/ Eric Powers, as Attorney-in-Fact	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.